36 results on '"Vonk, Alieke G"'
Search Results
2. Paradoxal Trends in Azole-Resistant Aspergillus fumigatus in a National Multicenter Surveillance Program, the Netherlands, 2013-2018.
- Author
-
Lestrade PPA, Buil JB, van der Beek MT, Kuijper EJ, van Dijk K, Kampinga GA, Rijnders BJA, Vonk AG, de Greeff SC, Schoffelen AF, van Dissel J, Meis JF, Melchers WJG, and Verweij PE
- Subjects
- Antifungal Agents pharmacology, Antifungal Agents therapeutic use, Drug Resistance, Fungal, Fungal Proteins genetics, Humans, Microbial Sensitivity Tests, Netherlands epidemiology, Aspergillus fumigatus genetics, Azoles pharmacology
- Abstract
We investigated the prevalence of azole resistance of Aspergillus fumigatus isolates in the Netherlands by screening clinical A. fumigatus isolates for azole resistance during 2013-2018. We analyzed azole-resistant isolates phenotypically by in vitro susceptibility testing and for the presence of resistance mutations in the Cyp51A gene. Over the 6-year period, 508 (11%) of 4,496 culture-positive patients harbored an azole-resistant isolate. Resistance frequency increased from 7.6% (95% CI 5.9%-9.8%) in 2013 (58/760 patients) to 14.7% (95% CI 12.3%-17.4%) in 2018 (112/764 patients) (p = 0.0001). TR
34 /L98H (69%) and TR46 /Y121F/T289A (17%) accounted for 86% of Cyp51A mutations. However, the mean voriconazole MIC of TR34 /L98H isolates decreased from 8 mg/L (2013) to 2 mg/L (2018), and the voriconazole-resistance frequency was 34% lower in 2018 than in 2013 (p = 0.0001). Our survey showed changing azole phenotypes in TR34 /L98H isolates, which hampers the use of current PCR-based resistance tests.- Published
- 2020
- Full Text
- View/download PDF
3. Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicenter study.
- Author
-
Mercier T, Dunbar A, de Kort E, Schauwvlieghe A, Reynders M, Guldentops E, Blijlevens NMA, Vonk AG, Rijnders B, Verweij PE, Lagrou K, and Maertens J
- Subjects
- Aged, Female, Galactose analogs & derivatives, Humans, Male, Mannans analysis, Middle Aged, Retrospective Studies, Sensitivity and Specificity, Bronchoalveolar Lavage Fluid microbiology, Chromatography, Affinity methods, Hematologic Diseases microbiology, Invasive Pulmonary Aspergillosis diagnosis
- Abstract
Fast diagnosis of invasive pulmonary aspergillosis (IPA) is essential as early adequate therapy improves survival. However, current microbiological methods suffer from a low sensitivity or a long turnaround time, often as a result of batching. Recently, two lateral flow assays for diagnosing IPA have been CE (Conformité Européenne)-marked and commercialized. These assays can be used for fast single sample testing. However, clinical validation and comparative studies are lacking. We therefore sought to evaluate and compare these assays in adult hematology patients. We retrospectively tested 235 bronchoalveolar lavage fluid (BALf) samples of adult hematology patients from four centers using the AspLFD (OLM Diagnostics) and the sōna Aspergillus galactomannan LFA (IMMY). Both tests were read out independently by two researchers and by a digital reader. We included 11 patients with proven IPA, 64 with probable IPA, 43 with possible fungal disease, and 117 controls with no signs of IPA. In cases of proven IPA, the performance of both assays was similar. In cases of proven and probable IPA, we found an identical specificity for both assays, but a higher sensitivity (0.83 vs 0.69, P = .008) and a better negative predictive value (0.89 vs 0.82, P = .009) for the LFA. Digital readout improved the diagnostic performance of both tests. In conclusion, both assays showed a good performance for the diagnosis of IPA in BALf from adult hematology patients. Results were further improved by using a digital reader, especially for weakly positive results., (© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2020
- Full Text
- View/download PDF
4. Mycovirus therapy for invasive pulmonary aspergillosis?
- Author
-
van de Sande WWJ and Vonk AG
- Subjects
- Animals, Humans, Aspergillus growth & development, Aspergillus virology, Biological Therapy methods, Fungal Viruses growth & development, Invasive Pulmonary Aspergillosis therapy
- Abstract
With the current revived interest in the use of bacteriophages for the treatment of bacterial infections, the study of mycoviruses as novel therapeutic solutions for invasive aspergillosis is the logical next step. Although ssRNA, dsRNA, and ssDNA mycoviruses have been identified, the majority of characterised mycoviruses have dsRNA genomes. Prevalence of dsRNA mycoviruses in Aspergillus spp. varies, and mycoviruses can have different effects on their fungal hosts: hypovirulence, hypervirulence, or a killer phenotype. Therapeutically, extracellular transmission of the mycovirus is essential. DsRNA mycoviruses lack an extracellular phase; however, a single ssDNA mycovirus with homologues in Aspergillus genomes has been described with an extracellular mode of transmission. Mycoviruses can induce hypovirulence or a killer phenotype, and both can be exploited therapeutically. Mycoviruses inducing hypovirulence have been used to control chestnut blight, however for aspergillosis no such mycovirus has been identified yet. Mycovirus encoded killer toxins or anti-idiotypic antibodies and killer peptides derived from these have been demonstrated to control fungal infections including aspergillosis in animals. This indicates that mycoviruses inducing both phenotypes could be exploited therapeutically as long as the right mycovirus has been identified., (© The Author(s) 2019. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology.)
- Published
- 2019
- Full Text
- View/download PDF
5. Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.
- Author
-
Schauwvlieghe AFAD, Rijnders BJA, Philips N, Verwijs R, Vanderbeke L, Van Tienen C, Lagrou K, Verweij PE, Van de Veerdonk FL, Gommers D, Spronk P, Bergmans DCJJ, Hoedemaekers A, Andrinopoulou ER, van den Berg CHSB, Juffermans NP, Hodiamont CJ, Vonk AG, Depuydt P, Boelens J, and Wauters J
- Subjects
- APACHE, Aged, Belgium epidemiology, Female, Humans, Incidence, Influenza, Human microbiology, Intensive Care Units statistics & numerical data, Invasive Pulmonary Aspergillosis microbiology, Male, Middle Aged, Netherlands epidemiology, Odds Ratio, Patient Admission statistics & numerical data, Retrospective Studies, Aspergillus, Influenza A virus, Influenza B virus, Influenza, Human epidemiology, Invasive Pulmonary Aspergillosis epidemiology
- Abstract
Background: Invasive pulmonary aspergillosis typically occurs in an immunocompromised host. For almost a century, influenza has been known to set up for bacterial superinfections, but recently patients with severe influenza were also reported to develop invasive pulmonary aspergillosis. We aimed to measure the incidence of invasive pulmonary aspergillosis over several seasons in patients with influenza pneumonia in the intensive care unit (ICU) and to assess whether influenza was an independent risk factor for invasive pulmonary aspergillosis., Methods: We did a retrospective multicentre cohort study. Data were collected from adult patients with severe influenza admitted to seven ICUs across Belgium and The Netherlands during seven influenza seasons. Patients were older than 18 years, were admitted to the ICU for more than 24 h with acute respiratory failure, had pulmonary infiltrates on imaging, and a confirmed influenza infection based on a positive airway PCR test (influenza cohort). We used logistic regression analyses to determine if influenza was independently associated with invasive pulmonary aspergillosis in non-immunocompromised (ie, no European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group [EORTC/MSG] host factor) influenza-positive patients (influenza case group) compared with non-immunocompromised patients with severe community-acquired pneumonia who had a negative airway influenza PCR test (control group)., Findings: Data were collected from patients admitted to the ICU between Jan 1, 2009, and June 30, 2016. Invasive pulmonary aspergillosis was diagnosed in 83 (19%) of 432 patients admitted with influenza (influenza cohort), a median of 3 days after admission to the ICU. The incidence was similar for influenza A and B. For patients with influenza who were immunocompromised, incidence of invasive pulmonary aspergillosis was as high as 32% (38 of 117 patients), whereas in the non-immunocompromised influenza case group, incidence was 14% (45 of 315 patients). Conversely, only 16 (5%) of 315 patients in the control group developed invasive pulmonary aspergillosis. The 90-day mortality was 51% in patients in the influenza cohort with invasive pulmonary aspergillosis and 28% in the influenza cohort without invasive pulmonary aspergillosis (p=0·0001). In this study, influenza was found to be independently associated with invasive pulmonary aspergillosis (adjusted odds ratio 5·19; 95% CI 2·63-10·26; p<0·0001), along with a higher APACHE II score, male sex, and use of corticosteroids., Interpretation: Influenza was identified as an independent risk factor for invasive pulmonary aspergillosis and is associated with high mortality. Future studies should assess whether a faster diagnosis or antifungal prophylaxis could improve the outcome of influenza-associated aspergillosis., Funding: None., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
6. The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole-resistance. A nationwide survey and rationale for the DB-MSG 002 study protocol.
- Author
-
Schauwvlieghe AFAD, de Jonge N, van Dijk K, Verweij PE, Brüggemann RJ, Biemond BJ, Bart A, von dem Borne PA, Verbon A, van der Beek MT, Demandt AMP, Oudhuis GJ, Cornelissen JJ, van der Velden WJFM, Span LFR, Kampinga GA, Bruns AH, Vonk AG, Haas PA, Doorduijn JK, and Rijnders BJA
- Subjects
- Academic Medical Centers, Antifungal Agents pharmacology, Aspergillus fumigatus drug effects, Azoles pharmacology, Chemoprevention methods, Humans, Invasive Pulmonary Aspergillosis prevention & control, Netherlands, Prevalence, Surveys and Questionnaires, Antifungal Agents administration & dosage, Azoles administration & dosage, Disease Management, Drug Resistance, Fungal, Hematologic Neoplasms complications, Invasive Pulmonary Aspergillosis diagnosis, Invasive Pulmonary Aspergillosis drug therapy
- Abstract
Patients with haematological malignancies are at risk for invasive fungal diseases (IFD). A survey was conducted in all Dutch academic haematology centres on their current diagnostic, prophylactic and therapeutic approach towards IFD in the context of azole-resistance. In all 8 centres, a haematologist and microbiologist filled in the questionnaire that focused on different subgroups of haematology patients. Fungal prophylaxis during neutropaenia was directed against Candida and consisted of fluconazole and/or amphotericin B suspension. Mould-active prophylaxis was given to acute myeloid leukaemia patients during chemotherapy in 2 of 8 centres. All centres used azole prophylaxis in a subset of patients with graft-versus-host disease. A uniform approach towards the diagnosis and treatment of IFD and in particular azole-resistant Aspergillus fumigatus was lacking. In 2017, all centres agreed to implement a uniform diagnostic and treatment algorithm regarding invasive aspergillosis with a central role for comprehensive diagnostics and PCR-based detection of azole-resistance. This study (DB-MSG 002) will re-evaluate this algorithm when 280 patients have been treated. A heterogeneous approach towards antifungal prophylaxis, diagnosis and treatment was apparent in the Netherlands. Facing triazole-resistance, consensus was reached on the implementation of a uniform diagnostic approach in all 8 centres., (© 2018 The Authors. Mycoses Published by Blackwell Verlag GmbH.)
- Published
- 2018
- Full Text
- View/download PDF
7. Chitinase Induction Prior to Caspofungin Treatment of Experimental Invasive Aspergillosis in Neutropenic Rats Does Not Enhance Survival.
- Author
-
Refos JM, Vonk AG, Ten Kate MT, Verbrugh HA, Bakker-Woudenberg IAJM, and van de Sande WWJ
- Subjects
- Animals, Antifungal Agents pharmacology, Aspergillus fumigatus drug effects, Aspergillus fumigatus pathogenicity, Chitosan chemistry, Chitosan pharmacology, Disease Models, Animal, Female, Invasive Pulmonary Aspergillosis metabolism, Invasive Pulmonary Aspergillosis prevention & control, Lung drug effects, Lung enzymology, Microbial Sensitivity Tests, Molecular Weight, Neutropenia microbiology, Rats, Aspergillus fumigatus metabolism, Caspofungin pharmacology, Chitinases metabolism, Invasive Pulmonary Aspergillosis drug therapy, Neutropenia complications
- Abstract
Host chitinases, chitotriosidase and acidic mammalian chitinase (AMCase), improved the antifungal activity of caspofungin (CAS) against Aspergillus fumigatus in vitro These chitinases are not constitutively expressed in the lung. Here, we investigated whether chitosan derivatives were able to induce chitinase activity in the lungs of neutropenic rats and, if so, whether these chitinases were able to prolong survival of rats with invasive pulmonary aspergillosis (IPA) or of rats with IPA and treated with CAS. An oligosaccharide-lactate chitosan (OLC) derivative was instilled in the left lung of neutropenic rats to induce chitotriosidase and AMCase activities. Rats instilled with OLC or with phosphate-buffered saline (PBS) were subsequently infected with A. fumigatus and then treated with suboptimal doses of CAS. Survival, histopathology, and galactomannan indexes were determined. Instillation of OLC resulted in chitotriosidase and AMCase activities. However, instillation of OLC did not prolong rat survival when rats were subsequently challenged with A. fumigatus In 5 of 7 rats instilled with OLC, the fungal foci in the lungs were smaller than those in rats instilled with PBS. Instillation of OLC did not significantly enhance the survival of neutropenic rats challenged with A. fumigatus and treated with a suboptimal dosage of CAS. Chitotriosidase and AMCase activities can be induced with OLC, but the presence of active chitinases in the lung did not prevent the development of IPA or significantly enhance the therapeutic outcome of CAS treatment., (Copyright © 2017 American Society for Microbiology.)
- Published
- 2017
- Full Text
- View/download PDF
8. Addition of 17-(allylamino)-17-demethoxygeldanamycin to a suboptimal caspofungin treatment regimen in neutropenic rats with invasive pulmonary aspergillosis delays the time to death but does not enhance the overall therapeutic efficacy.
- Author
-
Refos JM, Vonk AG, Ten Kate MT, Eadie K, Verbrugh HA, Bakker-Woudenberg IAJM, and van de Sande WWJ
- Subjects
- Animals, Antifungal Agents administration & dosage, Aspergillus fumigatus drug effects, Benzoquinones toxicity, Caspofungin, Disease Models, Animal, Drug Synergism, Drug Therapy, Combination, Female, Humans, Invasive Pulmonary Aspergillosis complications, Invasive Pulmonary Aspergillosis microbiology, Lactams, Macrocyclic toxicity, Microbial Sensitivity Tests, Neutropenia complications, Rats, Benzoquinones administration & dosage, Echinocandins administration & dosage, Invasive Pulmonary Aspergillosis drug therapy, Lactams, Macrocyclic administration & dosage, Lipopeptides administration & dosage
- Abstract
Caspofungin (CAS) which is used as salvage therapy in patients with invasive pulmonary aspergillosis (IPA) inhibits the 1,3-β-D-glucan synthesis in Aspergillus fumigatus. Inhibiting 1,3-β-D-glucan synthesis induces a stress response and in an invertebrate model it was demonstrated that inhibiting this response with geldamycin enhanced the therapeutic efficacy of CAS. Since geldamycin itself is toxic to mammalians, the therapeutic efficacy of combining geldamycin with CAS was not studied in rodent models. Therefore in this study we investigated if the geldamycin derivate 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) was able to enhance the therapeutic efficacy of CAS in vitro and in our IPA model in transiently neutropenic rats. In vitro we confirmed the earlier demonstrated synergy between 17-AAG and CAS in ten A. fumigatus isolates. In vivo we treated A. fumigatus infected neutropenic rats with a sub-optimal dose of 0.75 mg/kg/day CAS and 1 mg/kg/day 17-AAG for ten days. Survival was monitored for 21 days after fungal inoculation. It appeared that the addition 17-AAG delayed death but did not improve overall survival of rats with IPA. Increasing the doses of 17-AAG was not possible due to hepatic toxicity. This study underlines the need to develop less toxic and more fungal specific geldamycin derivatives and the need to test such drugs not only in invertebrate models but also in mammalian models.
- Published
- 2017
- Full Text
- View/download PDF
9. Echinocandin to fluconazole step-down therapy in critically ill patients with invasive, susceptible Candida albicans infections.
- Author
-
van der Geest PJ, Rijnders BJ, Vonk AG, and Groeneveld AB
- Subjects
- Administration, Intravenous, Adult, Aged, Anidulafungin, Antifungal Agents administration & dosage, Antifungal Agents classification, Caspofungin, Critical Illness, Echinocandins administration & dosage, Female, Fluconazole administration & dosage, Humans, Intensive Care Units, Lipopeptides administration & dosage, Lipopeptides therapeutic use, Male, Micafungin, Middle Aged, Multivariate Analysis, Retrospective Studies, Antifungal Agents therapeutic use, Candidiasis, Invasive drug therapy, Echinocandins therapeutic use, Fluconazole therapeutic use
- Abstract
Invasive Candida spp. infections are increasingly diagnosed in critically ill patients. For initial treatment, an echinocandin is recommended with a possible step-down to fluconazole when the patients' condition is improving and the isolate appears susceptible, but there are no data to support such policy. We studied the safety and efficacy of step-down therapy in critically ill patients with culture proven deep seated or bloodstream infections by C. albicans susceptible to fluconazole. All patients admitted into the intensive care unit from January 2010 to December 2014, who had a culture proven invasive C. albicans infection and received initial treatment with an echinocandin for at least 4 days were included. Data on patient characteristics, treatment and vital outcomes were assessed. Of the 56 patients, 32 received step-down fluconazole therapy, at median day 5, whereas the echinocandin was continued in the other 24. No differences where seen in baseline characteristics or risk factors for invasive C. albicans infection between the two groups. Response rates were similar and no difference where seen in 28-day or 90-day mortality between the groups. Step-down therapy to fluconazole may be safe and effective in critically ill patients with invasive infections by C. albicans, susceptible to fluconazole, who have clinically improved as early as 4 days after start of treatment with an echinocandin., (© 2015 Blackwell Verlag GmbH.)
- Published
- 2016
- Full Text
- View/download PDF
10. Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid.
- Author
-
Chong GL, van de Sande WW, Dingemans GJ, Gaajetaan GR, Vonk AG, Hayette MP, van Tegelen DW, Simons GF, and Rijnders BJ
- Subjects
- Aspergillus drug effects, Cytochrome P-450 Enzyme System genetics, Female, Fungal Proteins genetics, Humans, Invasive Pulmonary Aspergillosis diagnosis, Invasive Pulmonary Aspergillosis microbiology, Male, Molecular Diagnostic Techniques methods, Mutant Proteins genetics, Mutation, Missense, Predictive Value of Tests, Retrospective Studies, Sensitivity and Specificity, Antifungal Agents pharmacology, Aspergillus isolation & purification, Azoles pharmacology, Bronchoalveolar Lavage Fluid microbiology, Microbiological Techniques methods, Multiplex Polymerase Chain Reaction methods, Real-Time Polymerase Chain Reaction methods
- Abstract
Azole resistance in Aspergillus fumigatus is increasingly reported. Here, we describe the validation of the AsperGenius, a new multiplex real-time PCR assay consisting of two multiplex real-time PCRs, one that identifies the clinically relevant Aspergillus species, and one that detects the TR34, L98H, T289A, and Y121F mutations in CYP51A and differentiates susceptible from resistant A. fumigatus strains. The diagnostic performance of the AsperGenius assay was tested on 37 bronchoalveolar lavage (BAL) fluid samples from hematology patients and 40 BAL fluid samples from intensive care unit (ICU) patients using a BAL fluid galactomannan level of ≥1.0 or positive culture as the gold standard for detecting the presence of Aspergillus. In the hematology and ICU groups combined, there were 22 BAL fluid samples from patients with invasive aspergillosis (IA) (2 proven, 9 probable, and 11 nonclassifiable). Nineteen of the 22 BAL fluid samples were positive, according to the gold standard. The optimal cycle threshold value for the presence of Aspergillus was <36. Sixteen of the 19 BAL fluid samples had a positive PCR (2 Aspergillus species and 14 A. fumigatus samples). This resulted in a sensitivity, specificity, and positive and negative predictive values of 88.9%, 89.3%, 72.7%, and 96.2%, respectively, for the hematology group and 80.0%, 93.3%, 80.0%, and 93.3%, respectively, in the ICU group. The CYP51A real-time PCR confirmed 12 wild-type and 2 resistant strains (1 TR34-L98H and 1 TR46-Y121F-T289A mutant). Voriconazole therapy failed for both patients. The AsperGenius multiplex real-time PCR assay allows for sensitive and fast detection of Aspergillus species directly from BAL fluid samples. More importantly, this assay detects and differentiates wild-type from resistant strains, even if BAL fluid cultures remain negative., (Copyright © 2015, American Society for Microbiology. All Rights Reserved.)
- Published
- 2015
- Full Text
- View/download PDF
11. Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
- Author
-
Chai LY, Kullberg BJ, Earnest A, Johnson EM, Teerenstra S, Vonk AG, Schlamm HT, Herbrecht R, Netea MG, and Troke PF
- Subjects
- Aspergillosis diagnosis, Aspergillosis microbiology, Aspergillosis mortality, Biomarkers blood, Female, Galactose analogs & derivatives, Hematologic Neoplasms diagnosis, Hematologic Neoplasms drug therapy, Hematologic Neoplasms microbiology, Hematologic Neoplasms mortality, Humans, Male, Survival Analysis, Treatment Outcome, Voriconazole, Amphotericin B therapeutic use, Antifungal Agents therapeutic use, Aspergillosis drug therapy, Fungal Polysaccharides blood, Mannans blood, Pyrimidines therapeutic use, Triazoles therapeutic use
- Abstract
An improved number of anti-fungal drugs are currently available for the treatment of invasive aspergillosis (IA). While serial galactomannan index (GMI) measurement can be used to monitor response to treatment, the extent to which different anti-fungal regimens can affect galactomannan levels is unknown. In 147 IA patients receiving either voriconazole (VCZ) or conventional amphotericin B (CAB) in a multicentre clinical trial, we performed post-hoc analyses of GMI trends in relation to outcomes. The generalized estimation equations approach was used to estimate changes in the effect size for GMI over time within patients. Patients who received VCZ primary therapy and had good treatment response 12 weeks later showed earlier decreases in GMI values at Week 1 and Week 2 (p = 0.001 and 0.046 respectively) as compared to patients who only received CAB. At end-of-randomized therapy (EORT), which was a pre-set secondary assessment point for all patients who switched from randomized primary (CAB or VCZ) to an alternative anti-fungal drug, treatment failure was associated with increasing GMI at Weeks 1 and 2 in CAB-primary treated patients (p = 0.022 and 0.046 respectively). These distinct trends highlight the variations in GMI kinetics with the use of different anti-fungal drugs and their implications in relation to IA treatment response.
- Published
- 2014
- Full Text
- View/download PDF
12. Double-stranded RNA mycovirus infection of Aspergillus fumigatus is not dependent on the genetic make-up of the host.
- Author
-
Refos JM, Vonk AG, Eadie K, Lo-Ten-Foe JR, Verbrugh HA, van Diepeningen AD, and van de Sande WW
- Subjects
- Aspergillus fumigatus genetics, Aspergillus fumigatus metabolism, Mycelium genetics, Mycelium metabolism, RNA Viruses genetics, RNA, Double-Stranded genetics, RNA, Viral genetics, Aspergillus fumigatus virology, Mycelium virology, RNA Viruses metabolism, RNA, Double-Stranded metabolism, RNA, Viral metabolism
- Abstract
Aspergillus fumigatus is a fungus that causes opportunistic infections in immunocompromised patients, with high morbidity and mortality. In its turn, A. fumigatus can become infected with mycoviruses. Most mycoviruses have a dsRNA genome and can cause fungal hypovirulence. For that reason, mycoviruses could theoretically be used as therapeutic tools to combat fungal infections. We determined if a certain genetic make-up of A. fumigatus was associated with the presence of mycoviruses in 86 clinical A. fumigatus isolates. Mycovirus screening was performed by isolating dsRNA from mycelial cultures using a Trizol/Chloroform method. The genetic relatedness of dsRNA infected A. fumigatus was determined by cell surface protein (CSP) typing and determination of the mating type. Sixteen (18.6%) of the 86 clinical A. fumigatus isolates contained dsRNA. The A. fumigatus collection could be divided into 11 different CSP types. DsRNA infected A. fumigatus isolates had similar CSP types as non-infected isolates. In both cases, the CSP types t01, t02, t03 and t04 were the most prevalent and the distribution comparable to the CSP types observed in other Dutch collections. Mating types MAT1-1 and MAT1-2 were evenly distributed among all A. fumigatus strains, regardless of CSP type. No difference was observed in mycovirus infections between MAT1-1 and MAT1-2 isolates. DsRNA mycovirus infections in A. fumigatus are not related to either CSP or mating type and therefore represent an interesting future therapeutic tool to combat fungal infections.
- Published
- 2013
- Full Text
- View/download PDF
13. An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity.
- Author
-
Chai LY, Netea MG, Tai BC, Khin LW, Vonk AG, Teo BW, Schlamm HT, Herbrecht R, Donnelly JP, Troke PF, and Kullberg BJ
- Subjects
- Adult, Aged, Amphotericin B administration & dosage, Antifungal Agents administration & dosage, Female, Humans, Male, Middle Aged, Serum chemistry, Acute Kidney Injury chemically induced, Acute Kidney Injury immunology, Amphotericin B adverse effects, Antifungal Agents adverse effects, Interleukin-10 blood, Interleukin-6 blood, Interleukin-8 blood
- Abstract
Objectives: The underlying mechanism for amphotericin B-induced acute kidney injury (AKI) remains poorly understood and may be immunologically mediated. We assessed whether the development of nephrotoxicity is linked to a distinct cytokine profile in patients receiving amphotericin B deoxycholate (AmBD)., Patients and Methods: In 58 patients who received AmBD, circulating serum interleukin (IL)-6, IL-8 and IL-10 were measured at baseline, week 1 and week 2 of antifungal treatment and correlated to the development of renal impairment. The Cox proportional hazards model approach was adopted for analysis., Results: The P value was 0.026 for the overall effect of IL-6 on time to development of AKI. An increasing or non-receding IL-6 trend by week 1 of AmBD treatment (followed by a decreasing or non-receding IL-6 trend from week 1 to week 2) correlated with an increased likelihood of nephrotoxicity [hazard ratio (HR) 6.93, P value 0.005 and HR 3.46, P value 0.035, respectively]. Similarly, persistently increasing IL-8 levels were linked to a 3.84-fold increased likelihood of AKI., Conclusions: In patients receiving AmBD, persistence of an elevated pro-inflammatory cytokine milieu is associated with a predisposition to drug-related kidney injury.
- Published
- 2013
- Full Text
- View/download PDF
14. Association of eumycetoma and schistosomiasis.
- Author
-
van Hellemond JJ, Vonk AG, de Vogel C, Koelewijn R, Vaessen N, Fahal AH, van Belkum A, and van de Sande WW
- Subjects
- Adolescent, Adult, Aged, Animals, Case-Control Studies, Comorbidity, Female, Humans, Male, Middle Aged, Mycetoma immunology, Schistosomiasis immunology, Seroepidemiologic Studies, Th2 Cells immunology, Young Adult, Coinfection epidemiology, Mycetoma complications, Mycetoma epidemiology, Schistosomiasis complications, Schistosomiasis epidemiology
- Abstract
Eumycetoma is a morbid chronic granulomatous subcutaneous fungal disease. Despite high environmental exposure to this fungus in certain regions of the world, only few develop eumycetoma for yet unknown reasons. Animal studies suggest that co-infections skewing the immune system to a Th2-type response enhance eumycetoma susceptibility. Since chronic schistosomiasis results in a strong Th2-type response and since endemic areas for eumycetoma and schistosomiasis do regionally overlap, we performed a serological case-control study to identify an association between eumycetoma and schistosomiasis. Compared to endemic controls, eumycetoma patients were significantly more often sero-positive for schistosomiasis (p = 0.03; odds ratio 3.2, 95% CI 1.18-8.46), but not for toxoplasmosis, an infection inducing a Th1-type response (p = 0.6; odds ratio 1.5, 95% CI 0.58-3.83). Here, we show that schistosomiasis is correlated to susceptibility for a fungal disease for the first time.
- Published
- 2013
- Full Text
- View/download PDF
15. Unrecognized norovirus infections in health care institutions and their clinical impact.
- Author
-
Beersma MF, Sukhrie FH, Bogerman J, Verhoef L, Mde Melo M, Vonk AG, and Koopmans M
- Subjects
- Adult, Child, Child, Preschool, Feces virology, Female, Humans, Incidence, Male, RNA, Viral genetics, RNA, Viral isolation & purification, Real-Time Polymerase Chain Reaction, Tertiary Care Centers, Caliciviridae Infections epidemiology, Caliciviridae Infections virology, Cross Infection epidemiology, Cross Infection virology, Gastroenteritis epidemiology, Gastroenteritis virology, Norovirus isolation & purification
- Abstract
Noroviruses (NoVs) have emerged as the leading cause of acute viral gastroenteritis (GE) in humans. Although diagnostic facilities have greatly improved, significant underdiagnosis of NoV in hospitals may still occur, thereby increasing clinical burden and nosocomial spread. We evaluated the underdiagnosis of sporadic NoV infections in a tertiary care hospital and estimated its clinical impact. From December 2008 until July 2009, fecal samples specifically referred for bacterial but not viral examination were retrospectively tested for NoV by real-time PCR. The clinical and virological data from patients with undiagnosed NoV infection (missed patients) were evaluated and compared with those from patients with recognized NoV. During the study period, 45 patients with undiagnosed NoV were detected, whereas 50 patients were regularly diagnosed. The missed NoV cases were more frequently adults than children (80% versus 46%; P < 0.001). The viral load levels did not differ between the diagnosed and missed patients, but missed patients more frequently presented without diarrhea (20% versus 4%; P < 0.07). The newly admitted missed NoV cases with GE underwent more diagnostic imaging (24% versus 4%; P < 0.01) and tended to be hospitalized longer. When missed-NoV patients were included, the number of nosocomial clusters doubled and missed patients were index cases in 5 of the 6 clusters. These data indicate that NoV infections are frequently missed despite routine laboratory testing and demonstrate that underdiagnosis of NoV patients is associated with costly abdominal imaging and nosocomial clustering. Awareness of NoV infection in adult patients and education about the importance of viral GE should be increased.
- Published
- 2012
- Full Text
- View/download PDF
16. Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis.
- Author
-
Chai LY, Kullberg BJ, Johnson EM, Teerenstra S, Khin LW, Vonk AG, Maertens J, Lortholary O, Donnelly PJ, Schlamm HT, Troke PF, Netea MG, and Herbrecht R
- Subjects
- Female, Galactose analogs & derivatives, Humans, Invasive Pulmonary Aspergillosis drug therapy, Invasive Pulmonary Aspergillosis mortality, Male, Prognosis, ROC Curve, Survival Analysis, Time Factors, Treatment Outcome, Biomarkers blood, Drug Monitoring methods, Invasive Pulmonary Aspergillosis diagnosis, Mannans blood, Serum chemistry
- Abstract
The monitoring and prediction of treatment responses to invasive aspergillosis (IA) are difficult. We determined whether serum galactomannan index (GMI) trends early in the course of disease may be useful in predicting eventual clinical outcomes. For the subjects recruited into the multicenter Global Aspergillosis Study, serial GMIs were measured at baseline and at weeks 1, 2, and 4 following antifungal treatment. Clinical response and survival at 12 weeks were the outcome measures. GMI trends were analyzed by using the generalized estimation equation approach. GMI cutoffs were evaluated by using receiver-operating curve analyses incorporating pre- and posttest probabilities. Of the 202 study patients diagnosed with IA, 71 (35.1%) had a baseline GMI of ≥ 0.5. Week 1 GMI was significantly lower for the eventual responders to treatment at week 12 than for the nonresponders (GMIs of 0.62 ± 0.12 and 1.15 ± 0.22, respectively; P = 0.035). A GMI reduction of >35% between baseline and week 1 predicted a probability of a satisfactory clinical response. For IA patients with pretreatment GMIs of <0.5 (n = 131; 64.9%), GMI ought to remain low during treatment, and a rising absolute GMI to >0.5 at week 2 despite antifungal treatment heralded a poor clinical outcome. Here, every 0.1-unit increase in the GMI between baseline and week 2 increased the likelihood of an unsatisfactory clinical response by 21.6% (P = 0.018). In summary, clinical outcomes may be anticipated by charting early GMI trends during the first 2 weeks of antifungal therapy. These findings have significant implications for the management of IA.
- Published
- 2012
- Full Text
- View/download PDF
17. Phagocytosis and intracellular killing of Candida albicans by murine polymorphonuclear neutrophils.
- Author
-
Vonk AG, Netea MG, and Kullberg BJ
- Subjects
- Animals, Mice, Neutrophils cytology, Candida albicans cytology, Candida albicans immunology, Microbial Viability, Neutrophils immunology, Phagocytosis
- Abstract
Polymorphonuclear neutrophils (PMNs) are important phagocytes in the control of Candida infections. The phagocytic contribution of PMNs to host defence can by assessed by various methods, such as microbiological assays. However, assessment and definition of intracellular killing capacity can be a source of considerable confusion. A comparison of the growth of Candida in the presence of PMN with the growth of Candida in phagocyte-free suspensions may lead to an overestimation of killing capacity because PMNs can use both intracellular and extracellular killing mechanisms. Here, we describe the use of an adherent monolayer of exudate peritoneal PMNs that is used to differentiate between the process of phagocytosis and intracellular killing.
- Published
- 2012
- Full Text
- View/download PDF
18. The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosis.
- Author
-
Chai LY, de Boer MG, van der Velden WJ, Plantinga TS, van Spriel AB, Jacobs C, Halkes CJ, Vonk AG, Blijlevens NM, van Dissel JT, Donnelly PJ, Kullberg BJ, Maertens J, and Netea MG
- Subjects
- Adult, Belgium, Case-Control Studies, Cytokines, Female, Flow Cytometry, Gene Frequency, Genotype, Hematopoietic Stem Cell Transplantation adverse effects, Heterozygote, Humans, Lectins, C-Type, Male, Membrane Proteins metabolism, Middle Aged, Nerve Tissue Proteins metabolism, Netherlands, Polymorphism, Single Nucleotide, beta-Glucans metabolism, Aspergillosis genetics, Aspergillosis immunology, Codon, Terminator genetics, Genetic Predisposition to Disease genetics, Membrane Proteins genetics, Nerve Tissue Proteins genetics
- Abstract
Background: Dectin-1 is the major receptor for fungal β-glucans on myeloid cells. We investigated whether defective Dectin-1 receptor function, because of the early stop codon polymorphism Y238X, enhances susceptibility to invasive aspergillosis (IA) in at-risk patients., Methods: Association of Dectin-1 Y238X polymorphism with occurrence and clinical course of IA was evaluated in 71 patients who developed IA post hematopoietic stem cell transplantation (HSCT) and in another 21 non-HSCT patients with IA. The control group consisted of 108 patients who underwent HSCT. Functional studies were performed to investigate consequences of the Y238X Dectin-1 polymorphism., Results: The Y238X allele frequency was higher in non-HSCT patients with IA (19.0% vs 6.9%-7.7%; P < .05). Heterozygosity for Y238X polymorphism in HSCT recipients showed a trend toward IA susceptibility (odds ratio, 1.79; 95% CI, .77-4.19; P = .17) but did not influence clinical course of IA. Functional assays revealed that although peripheral blood mononuclear cells with defective Dectin-1 function due to Y238X responded less efficiently to Aspergillus, corresponding macrophages showed adequate response to Aspergillus., Conclusions: Dectin-1 Y238X heterozygosity has a limited influence on susceptibility to IA and may be important in susceptible non-HSCT patients. This is partly attributable to redundancy inherent in the innate immune system. Larger studies are needed to confirm these findings.
- Published
- 2011
- Full Text
- View/download PDF
19. Aspergillus fumigatus cell wall components differentially modulate host TLR2 and TLR4 responses.
- Author
-
Chai LY, Vonk AG, Kullberg BJ, Verweij PE, Verschueren I, van der Meer JW, Joosten LA, Latgé JP, and Netea MG
- Subjects
- Animals, Aspergillus fumigatus growth & development, Cell Extracts immunology, Cells, Cultured, Cytokines immunology, Humans, Interleukin-6 immunology, Lectins, C-Type, Membrane Proteins immunology, Mice, Mice, Inbred C57BL, Nerve Tissue Proteins immunology, Polysaccharides immunology, Signal Transduction, Aspergillosis immunology, Aspergillus fumigatus immunology, Aspergillus fumigatus metabolism, Cell Wall chemistry, Cell Wall metabolism, Toll-Like Receptor 2 immunology, Toll-Like Receptor 4 immunology
- Abstract
Aspergillus fumigatus conidia attenuates host proinflammatory responses through modulation of Toll-like receptor (TLR)2 and TLR4 signaling, but the precise mechanisms that mediate this effect are not known. In the present study, the role of the Aspergillus cell wall polysaccharide constituents responsible for the modulation of host capability to mount a proinflammatory response was studied. Aspergillus cell wall fractions and its major components showed differential capabilities in modulating host TLR-mediated interleukin (IL)-6 production. Beta-glucan specifically suppressed TLR4-induced response, while alpha-glucan inhibited IL-6 induced through TLR2- and TLR4-stimulation. Galactomannan diminished TLR4-mediated response, while its inhibitory effects on TLR2-signaling were limited. Chitin, on the other hand, did not have significant immunomodulatory capability. The ability of the fungal cell wall to alter the immune signature of the pathogen may contribute to its virulence and the pathogenesis of co-infection., (© 2010 Institut Pasteur. Published by Elsevier SAS. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
20. Immune response to Aspergillus fumigatus in compromised hosts: from bedside to bench.
- Author
-
Chai LY, Vonk AG, Kullberg BJ, and Netea MG
- Subjects
- Antifungal Agents therapeutic use, Aspergillosis drug therapy, Cytokines, Humans, Immunity, Innate, Opportunistic Infections drug therapy, Opportunistic Infections immunology, Phagocytes, Risk Factors, Aspergillosis immunology, Aspergillus fumigatus immunology, Immunocompromised Host
- Abstract
The relevance of studies aimed at understanding host immune response against Aspergillus fumigatus takes on much significance given that all patients with invasive aspergillosis are invariably immunocompromised. This article attempts to correlate relevant findings from recent experimental studies to clinical observations made by the physician at the bedside. It is hoped that the increased understanding of host-fungus immune interaction may pave the way for the development of new management strategies against this difficult-to-treat fungal disease.
- Published
- 2011
- Full Text
- View/download PDF
21. Differential susceptibility to lethal endotoxaemia in mice deficient in IL-1α, IL-1β or IL-1 receptor type I.
- Author
-
Joosten LA, Van De Veerdonk FL, Vonk AG, Boerman OC, Keuter M, Fantuzzi G, Verschueren I, Van Der Poll T, Dinarello CA, Kullberg BJ, Van Der Meer JW, and Netea MG
- Subjects
- Animals, Interleukin 1 Receptor Antagonist Protein pharmacology, Interleukin-1alpha immunology, Interleukin-1beta immunology, Kaplan-Meier Estimate, Lipopolysaccharides administration & dosage, Macrophages, Peritoneal immunology, Mice, Mice, Inbred C57BL, Mice, Knockout, Receptors, Interleukin-1 antagonists & inhibitors, Receptors, Interleukin-1 immunology, Specific Pathogen-Free Organisms, Endotoxemia immunology, Interleukin-1alpha deficiency, Interleukin-1beta deficiency, Receptors, Interleukin-1 deficiency
- Abstract
The role of intereukin-1 (IL-1) in mortality caused by endotoxaemia remains controversial. While IL-1 receptor antagonist (IL-1Ra) protects mice from lethal endotoxaemia, mice deficient in IL-1β (IL-1β⁻( /)⁻) display normal susceptibility to lipopolysaccharide (LPS). The aim of this study was to identify the source of these discrepancies. Mice deficient in IL-1α, IL-1β or IL-1R type I were injected intraperitoneally with Escherichia coli or Salmonella typhimurium LPS. Survival of the mice was examined and compared with C57/Bl6 wild-type mice. In addition, serum cytokine concentrations were determined after LPS challenge and in vitro cytokine production by peritoneal macrophages was analysed. Clearance of radioactive IL-1α was examined in IL-1α⁻(/)⁻ and wild-type mice. IL-1β⁻(/)⁻ mice were normally susceptible to endotoxaemia and cytokine production did not differ from that in control mice. Surprisingly, LPS mortality in IL-1α⁻(/)⁻ mice was significantly greater than that in control mice, accompanied by higher interferon-γ release. These effects were mediated by a distorted homeostasis of IL-1RI receptors, as shown by a strongly delayed clearance of IL-1α. In contrast to the IL-1α⁻(/)⁻ and IL-1β⁻(/)⁻ mice, IL-1RI⁻(/)⁻ mice were completely resistant to high doses of LPS. In conclusion, IL-1RI-mediated signals are crucial in mediating mortality occurring as a result of lethal endotoxaemia. Investigation of IL-1-mediated pathways in IL-1 knock-out mice is complicated by a distorted homeostasis of IL-1Rs., (© 2010 The Authors. APMIS © 2010 APMIS.)
- Published
- 2010
- Full Text
- View/download PDF
22. Early proinflammatory cytokines and C‐reactive protein trends as predictors of outcome in invasive Aspergillosis.
- Author
-
Chai L, Netea MG, Teerenstra S, Earnest A, Vonk AG, Schlamm HT, Herbrecht R, Troke PF, and Kullberg BJ
- Subjects
- Adult, Aged, Antifungal Agents therapeutic use, Aspergillosis drug therapy, Aspergillosis pathology, Cohort Studies, Female, Humans, Male, Middle Aged, Prognosis, Treatment Outcome, Aspergillosis diagnosis, Aspergillosis immunology, C-Reactive Protein analysis, Cytokines blood
- Abstract
Background: Monitoring treatment response in invasive aspergillosis is challenging, because an immunocompromised host may not exhibit reliable symptoms and clinical signs. Cytokines play a pivotal role in mediating host immune response to infection; therefore, the profiling of biomarkers may be an appropriate surrogate for disease status., Methods: We studied, in a cohort of 119 patients with invasive aspergillosis who were recruited in a multicenter clinical trial, serum interleukin (IL)-6, IL‐8, IL‐10, interferon‐γ, and C‐reactive protein (CRP) trends over the first 4 weeks of therapy and correlated these trends to clinical outcome parameters., Results: Circulating IL‐6 and CRP levels were high at initiation of therapy and generally showed a downward trend with antifungal treatment. However, subjects with adverse outcomes exhibited a distinct lack of decline in IL‐6 and CRP levels at week 1, compared with responders (P = .02, for both IL‐6 and CRP). Nonresponders also had significantly elevated IL‐8 levels (P = .001)., Conclusions: High initial IL‐8 and persistently elevated IL‐6, IL‐8, and CRP levels after initiation of treatment may be early predictors of adverse outcome in invasive aspergillosis. Cytokine and CRP profiles could be used for early identification of patients with a poor response to antifungal treatment who may benefit from more‐aggressive antimicrobial regimens.
- Published
- 2010
- Full Text
- View/download PDF
23. Aspergillus fumigatus conidial melanin modulates host cytokine response.
- Author
-
Chai LY, Netea MG, Sugui J, Vonk AG, van de Sande WW, Warris A, Kwon-Chung KJ, and Kullberg BJ
- Subjects
- Aspergillosis microbiology, Cells, Cultured, Cytokines biosynthesis, Host-Pathogen Interactions, Humans, Leukocytes, Mononuclear, Virulence, Aspergillosis immunology, Aspergillus fumigatus immunology, Aspergillus fumigatus pathogenicity, Melanins immunology, Spores, Fungal immunology
- Abstract
Melanin biopigments have been linked to fungal virulence. Aspergillus fumigatus conidia are melanised and are weakly immunogenic. We show that melanin pigments on the surface of resting Aspergillus fumigatus conidia may serve to mask pathogen-associated molecular patterns (PAMPs)-induced cytokine response. The albino conidia induced significantly more proinflammatory cytokines in human peripheral blood mononuclear cells (PBMC), as compared to melanised wild-type conidia. Blocking dectin-1 receptor, Toll-like receptor 4 or mannose receptor decreased cytokine production induced by the albino but not by the wild type conidia. Moreover, albino conidia stimulated less potently, cytokine production in PBMC isolated from an individual with defective dectin-1, compared to the stimulation of cells isolated from healthy donors. These results suggest that β-glucans, but also other stimulatory PAMPs like mannan derivatives, are exposed on conidial surface in the absence of melanin. Melanin may play a modulatory role by impeding the capability of host immune cells to respond to specific ligands on A. fumigatus., (Copyright © 2009 Elsevier GmbH. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
24. Anti-Aspergillus human host defence relies on type 1 T helper (Th1), rather than type 17 T helper (Th17), cellular immunity.
- Author
-
Chai LY, van de Veerdonk F, Marijnissen RJ, Cheng SC, Khoo AL, Hectors M, Lagrou K, Vonk AG, Maertens J, Joosten LA, Kullberg BJ, and Netea MG
- Subjects
- Cell Separation, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Humans, Interleukin-17 biosynthesis, Leukocytes, Mononuclear immunology, Macrophages immunology, T-Lymphocyte Subsets metabolism, Th1 Cells metabolism, Aspergillosis immunology, Aspergillus fumigatus immunology, Interleukin-17 immunology, T-Lymphocyte Subsets immunology, T-Lymphocytes, Helper-Inducer immunology, Th1 Cells immunology
- Abstract
Both interferon-gamma-producing type 1 T helper (Th1)- and interleukin-17 (IL-17)-producing Th17 cells have been proposed to be involved in anti-fungal host defence. Although invasive aspergillosis is one of the most severe human fungal infections, little is known regarding the relative importance of the Th1 versus Th17 cellular immune pathways for the human anti-Aspergillus host defence. Using human peripheral blood mononuclear cells and a system consisting of monocyte-derived macrophages with lymphocytes, we found that Aspergillus fumigatus is a weak inducer of human IL-17 but induces a strong Th1 response. These data were validated by the very low IL-17 levels in bronchoalveolar lavage fluid and serum of patients with invasive aspergillosis. Surprisingly, live A. fumigatus reduced IL-17 production induced by mitogenic stimuli. This effect was mediated through the propensity of A. fumigatus to metabolize tryptophan and release kynurenine, which modulates the inflammatory response through inhibition of IL-17 production. In conclusion, A. fumigatus does not stimulate production of IL-17 and human host defence against aspergillosis may not rely on potent Th17 responses.
- Published
- 2010
- Full Text
- View/download PDF
25. Fungal strategies for overcoming host innate immune response.
- Author
-
Chai LY, Netea MG, Vonk AG, and Kullberg BJ
- Subjects
- Fungi physiology, Host-Parasite Interactions, Humans, Mycoses microbiology, Fungi immunology, Immunity, Innate, Mycoses immunology
- Abstract
A successful pathogen is one that is able to effectively survive and evade detection by the host innate immune defense. Fungal pathogens have adopted strategies which evade host defense and eventually cause disease in at-risk patients. Shielding of stimulatory surface recognition molecules, shedding of decoy components, induction of anti-inflammatory signals, complement evasion and resilient survival capacity are successful evasion mechanisms employed by fungal pathogens. Understanding these complex pathways of immune evasion can potentially contribute to development of novel therapeutic strategies against fungal infections.
- Published
- 2009
- Full Text
- View/download PDF
26. Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus.
- Author
-
Chai LY, Kullberg BJ, Vonk AG, Warris A, Cambi A, Latgé JP, Joosten LA, van der Meer JW, and Netea MG
- Subjects
- Humans, Hyphae immunology, Immune Tolerance, Interleukin-1beta biosynthesis, Interleukin-6 biosynthesis, Spores, Fungal immunology, Aspergillus fumigatus immunology, Interleukin-1beta antagonists & inhibitors, Interleukin-6 antagonists & inhibitors, Toll-Like Receptor 2 immunology, Toll-Like Receptor 4 immunology
- Abstract
Toll-like receptor (TLR)-based signaling pathways in the host may be modulated by pathogens during the course of infection. We describe a novel immunomodulatory mechanism in which Aspergillus fumigatus conidia induce attenuation of TLR2- and TLR4-mediated interleukin (IL)-6 and IL-1beta proinflammatory responses in human mononuclear cells with suppression of IL-1beta mRNA transcription. Background TLR2 and TLR4 mRNA transcription was not influenced. A. fumigatus conidia induced TLR2 internalization and uptake into the phagosome with a resultant decrease in surface receptor expression. A. fumigatus hyphae, on the other hand, selectively downregulated the TLR4-mediated response. These novel immunosuppressive effects may facilitate the invasiveness of A. fumigatus.
- Published
- 2009
- Full Text
- View/download PDF
27. Host defence against disseminated Candida albicans infection and implications for antifungal immunotherapy.
- Author
-
Vonk AG, Netea MG, van der Meer JW, and Kullberg BJ
- Subjects
- Adjuvants, Immunologic economics, Animals, Candidiasis immunology, Candidiasis prevention & control, Complement System Proteins immunology, Dendritic Cells immunology, Drug Therapy, Combination, Fluconazole therapeutic use, Fungal Vaccines administration & dosage, Granulocyte Colony-Stimulating Factor therapeutic use, Humans, Immunity, Cellular drug effects, Immunity, Innate drug effects, Interferon-gamma therapeutic use, Killer Cells, Natural immunology, Phagocytes immunology, Randomized Controlled Trials as Topic economics, Receptors, Pattern Recognition immunology, Recombinant Proteins, Th1 Cells immunology, Th2 Cells immunology, Adjuvants, Immunologic therapeutic use, Antifungal Agents therapeutic use, Candida albicans immunology, Candidiasis drug therapy
- Abstract
The different manifestations of Candida albicans infection are dictated by an underlying defect in the immune response of the host. Protective immunity to disseminated candidiasis, the manifestation of C. albicans infection discussed in this review, has traditionally been ascribed to innate immunity with emphasis on the role of granulocytes. Lately, however, immunological studies have learned that host defence against disseminated candidiasis is based on a complex interplay between innate and cell-mediated immunity. Despite the availability of new antifungal agents, mortality associated with disseminated C. albicans infection remains high. Immunotherapy that augments host defence is an important strategic option in the battle against disseminated candidiasis. Here, the authors review the chronological events in the pathogenesis of disseminated candidiasis that aid in predicting the impact of existing immunotherapy and the development of future immunomodulating strategies.
- Published
- 2006
- Full Text
- View/download PDF
28. Endogenous interleukin (IL)-1 alpha and IL-1 beta are crucial for host defense against disseminated candidiasis.
- Author
-
Vonk AG, Netea MG, van Krieken JH, Iwakura Y, van der Meer JW, and Kullberg BJ
- Subjects
- Animals, Candida albicans immunology, Candidiasis microbiology, Candidiasis mortality, Candidiasis pathology, Disease-Free Survival, Immunocompetence immunology, Interferon-gamma metabolism, Kidney microbiology, Kidney pathology, Mice, Mice, Inbred C57BL, Mice, Knockout, Spleen cytology, Candida albicans pathogenicity, Candidiasis immunology, Interleukin-1 immunology
- Abstract
Background: Interleukin (IL)-1 alpha and IL-1 beta are protective proinflammatory cytokines involved in host defense against Candida albicans. It is, however, unknown whether they provide protection through similar mechanisms. We investigated the effect of endogenous IL-1 alpha and IL-1 beta on disseminated C. albicans infection., Methods: Mice deficient in the genes encoding IL-1 alpha (IL-1 alpha-/-), IL-1 beta (IL-1 beta-/-), or both molecules (IL-1 alpha-/- beta-/-) were used. Survival and C. albicans outgrowth in the kidneys was assessed after intravenous injection of C. albicans., Results: Both mortality and C. albicans outgrowth in the kidneys were significantly increased in IL-1 alpha-/- and IL-1 beta-/- mice, compared with those in control mice, with the IL-1 alpha-/- beta-/- mice being most susceptible to disseminated candidiasis. The host defense mechanisms triggered by IL-1 alpha and IL-1 beta differed from one another. IL-1 beta-/- mice showed decreased recruitment of granulocytes in response to an intraperitoneal C. albicans challenge, and generation of superoxide production was diminished in IL-1 beta-/- granulocytes. IL-1 alpha-/- mice had a reduced capacity to damage C. albicans pseudohyphae. Protective type 1 responses were deficient in both IL-1 alpha-/- and IL-1 beta-/- mice, as assessed by production of interferon-gamma by splenocytes in response to heat-killed C. albicans., Conclusion: Although IL-1 alpha and IL-1 beta have differential effects on the various arms of host defense, both cytokines are essential for mounting a protective host response against invasive C. albicans infection.
- Published
- 2006
- Full Text
- View/download PDF
29. Influence of endogenous pro-inflammatory cytokines on neutrophil-mediated damage of Candida albicans pseudohyphae, quantified in a modified tetrazolium dye assay.
- Author
-
Vonk AG, Wieland CW, Versteegen M, Verschueren IC, Netea MG, Joostent LA, Verweij PE, and Kullberg BJ
- Subjects
- Animals, Hyphae immunology, Indicators and Reagents, Interferon-gamma deficiency, Interleukins deficiency, Lymphotoxin-alpha deficiency, Mice, Mice, Inbred C57BL, Mice, Knockout, Specific Pathogen-Free Organisms, Statistics, Nonparametric, Tetrazolium Salts, Tumor Necrosis Factor-alpha deficiency, Candida albicans immunology, Interferon-gamma immunology, Interleukins immunology, Lymphotoxin-alpha immunology, Neutrophils immunology, Tumor Necrosis Factor-alpha immunology
- Abstract
For quantitative assessment of polymorphonuclear granulocyte (PMN)-mediated pseudohyphal damage, an improved tetrazolium (2,3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide; XTT) dye assay was developed. The modified assay proved to be a reliable indicator of viable pseudohyphal inoculum sizes. In addition, the influence of various endogenous pro-inflammatory cytokines on the capacity of PMN to damage Candida albicans pseudohyphae was investigated. PMN obtained from mice in which the genes encoding for tumor necrosis factor-alpha/lymphotoxin-alpha (TNF/LT), interferon-gamma (IFNgamma), interleukin (IL)-1alpha, or IL-1beta were disrupted, showed a significantly reduced pseudohyphal damage capacity in comparison with control PMN. The reduction amounted 25% for TNF-/- LT-/-, 11% for IFNgamma-/-, 21% for IL-1alpha-/-, and 34% for IL-1alpha-/-beta-/- PMN. In contrast, deficiency of IL-12 or IL-18 did not result in a diminished capacity to damage pseudohyphae and the capacity of PMN to damage Candida pseudohyphae was even slightly increased by 10% in IL-18-/- mice. These data suggest that endogenous pro-inflammatory cytokines are able to modulate antihyphal activity of PMN, the main effector cells against disseminated candidiasis by virtue of their capacity to kill both Candida blastoconidia and pseudohyphae.
- Published
- 2005
- Full Text
- View/download PDF
30. Effect of recombinant murine granulocyte colony-stimulating factor with or without fluoroquinolone therapy on mixed-infection abscesses in mice.
- Author
-
Stearne LE, Vonk AG, Kullberg BJ, and Gyssens IC
- Subjects
- Abscess microbiology, Animals, Anti-Infective Agents pharmacology, Aza Compounds pharmacology, Aza Compounds therapeutic use, Bacillus pathogenicity, Colony Count, Microbial, Cytokines metabolism, Escherichia coli pathogenicity, Female, Fluoroquinolones pharmacology, Granulocyte Colony-Stimulating Factor pharmacology, Mice, Mice, Inbred BALB C, Microbial Sensitivity Tests, Moxifloxacin, Quinolines pharmacology, Quinolines therapeutic use, Recombinant Proteins, Spleen microbiology, Survival Analysis, Treatment Outcome, Abscess drug therapy, Anti-Infective Agents therapeutic use, Fluoroquinolones therapeutic use, Granulocyte Colony-Stimulating Factor therapeutic use
- Abstract
The aim of the study was to determine if immunomodulation of host defense with recombinant murine granulocyte colony-stimulating factor (G-CSF) improves the efficacy of trovafloxacin or moxifloxacin in abscesses containing Bacillus fragilis ATCC 23745 and different Escherichia coli strains varying in virulence. Treatment of mice inoculated with 10(7) CFU B. fragilis and 10(5) CFU low-virulence E. coli with either trovafloxacin (150 mg/kg/day every 24 hours, days 3 to 7) or moxifloxacin (96 mg/kg/day every 12 hours, days 3 to 7), significantly reduced the number of B. fragilis to 6.9 +/- 0.35 and 5.8 +/- 0.10 and that of E. coli to 4.9 +/- 0.09 and 4.2 +/- 0.07 log CFU/abscess for trovafloxacin and moxifloxacin, respectively, compared to controls (B. fragilis 8.7 and E. coli 7.4 log CFU/abscess) on day 8. Also, moxifloxacin was more potent than trovafloxacin. Addition of G-CSF prophylaxis (1 mug once on day -1) or therapy (1 mug/day on days 3 to 7) to fluoroquinolone treatment did not improve the efficacy of fluoroquinolone therapy alone. The effect of moxifloxacin with or without G-CSF prophylaxis on abscesses with a virulent hemolytic E. coli strain was also studied. In moxifloxacin-treated mice, 75% survived infection compared to 10% of controls. Combining moxifloxacin with G-CSF prophylaxis significantly decreased survival (30%) compared to moxifloxacin alone. In addition, G-CSF prophylaxis resulted in a threefold (E. coli) to 100-fold (B. fragilis) increased outgrowth in the abscesses of surviving mice. In conclusion, the addition of G-CSF to a fluoroquinolone is not advisable since, depending on the virulence of the E. coli strains, this might detrimentally influence the outcome of therapy.
- Published
- 2005
- Full Text
- View/download PDF
31. Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis.
- Author
-
Vonk AG, De Bont N, Netea MG, Demacker PN, van der Meer JW, Stalenhoef AF, and Kullberg BJ
- Subjects
- Animals, Apolipoproteins E blood, Apolipoproteins E deficiency, Apolipoproteins E genetics, Candida albicans growth & development, Candidiasis microbiology, Candidiasis mortality, Fungemia microbiology, Fungemia mortality, Hyperlipoproteinemias complications, Lipoproteins, VLDL metabolism, Mice, Mice, Inbred C57BL, Apolipoproteins E physiology, Candida albicans pathogenicity, Candidiasis genetics, Candidiasis physiopathology, Genetic Predisposition to Disease
- Abstract
The effect of hyperlipoproteinemia on systemic candidiasis was investigated by assessing the susceptibility of hyperlipoproteinemic, apolipoprotein E (ApoE)-deficient (ApoE -/-) mice to a systemic Candida albicans infection. The absence of ApoE in these mice resulted in an eightfold increase in plasma lipoprotein concentrations in the very low-density lipoprotein (VLDL) fraction, as compared with levels seen in ApoE +/+ mice. Mortality due to candidemia was significantly higher (86%) in ApoE -/- mice than in ApoE+/+ mice (52%), and in platings of homogenized kidney material on fungal culture medium, ApoE -/- mice yielded significantly higher levels of C. albicans outgrowth than did ApoE+/+ mice. C albicans grew twofold better in ApoE -/- plasma in 4 h than in ApoE+/+ plasma, and depletion of lipoproteins from plasma resulted in a significant seven- to tenfold increase in C. albicans growth. Recombinant ApoE did not directly inhibit C. albicans growth. Our data indicate that the increased susceptibility of ApoE -/- mice to C albicans is due both to increased growth of blastoconidia in ApoE -/- mice in response to the availability of lipids as nutrients, and to the neutralization of candidacidal factors by lipoproteins. This study suggests that lipoproteins play a significant role in host defense against candidiasis.
- Published
- 2004
- Full Text
- View/download PDF
32. Differential role of IL-18 and IL-12 in the host defense against disseminated Candida albicans infection.
- Author
-
Netea MG, Vonk AG, van den Hoven M, Verschueren I, Joosten LA, van Krieken JH, van den Berg WB, Van der Meer JW, and Kullberg BJ
- Subjects
- Animals, Cytokines biosynthesis, Interferon-gamma biosynthesis, Mice, Mice, Inbred C57BL, Monocytes immunology, Neutrophils immunology, Phagocytosis, Candidiasis immunology, Interleukin-12 physiology, Interleukin-18 physiology
- Abstract
IFN-gamma plays a crucial role in the defense against infection with Candida albicans. Since IL-18 and IL-12 are strong stimuli of IFN-gamma production, we investigated whether endogenous IL-18 and IL-12 are involved in the host defense during disseminated candidiasis. IL-18 knockout (IL-18-/-) mice, but not IL-12-/- mice, displayed an increased mortality due to C. albicans infection, accompanied by a decreased clearance of the yeasts from the kidneys late during the course of infection. Histopathology of the organs, combined with phagocyte recruitment experiments, showed a decreased influx of monocytes at the sites of Candida infection, mainly in the IL-18-/- mice. Whereas production of the chemokine KC was decreased in both IL-18-/- and IL-12-/- mice, MIP-2 production was deficient only in IL-18-/- animals, which may explain the differences in phagocyte recruitment. In addition, although IFN-gamma production capacity, as a parameter of the Th1-protective immunity, was reduced by 65 to 80% in the IL-12-/- mice, this defect was even more pronounced in the IL-18-/- mice (85 to 95% down-modulation). In conclusion, the anticandidal effects of endogenous IL-18 are mediated late during the infection by assuring a proper IFN-gamma response and promoting the infiltration of the site of infection by monocytes.
- Published
- 2003
- Full Text
- View/download PDF
33. Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor.
- Author
-
Vonk AG, Netea MG, van Krieken JH, Verweij PE, van der Meer JW, and Kullberg BJ
- Subjects
- Adjuvants, Immunologic pharmacokinetics, Adjuvants, Immunologic therapeutic use, Amphotericin B pharmacokinetics, Amphotericin B therapeutic use, Animals, Antifungal Agents pharmacokinetics, Cytokines biosynthesis, Female, Fluconazole therapeutic use, Granulocyte Colony-Stimulating Factor pharmacokinetics, Lymphocytes drug effects, Lymphocytes immunology, Mice, Mice, Inbred CBA, Microbial Sensitivity Tests, Recombinant Proteins pharmacokinetics, Recombinant Proteins therapeutic use, Spleen cytology, Spleen drug effects, Treatment Outcome, Abdominal Abscess drug therapy, Abdominal Abscess microbiology, Antifungal Agents therapeutic use, Candida albicans drug effects, Granulocyte Colony-Stimulating Factor therapeutic use
- Abstract
The aim of the present study was to assess the influence of immunomodulation of host defense with recombinant murine granulocyte colony-stimulating factor (rmG-CSF) on intra-abdominal abscesses caused by Candida albicans. Mice received prophylaxis or therapy with 1 microg of rmG-CSF/day in the presence or absence of antifungal treatment consisting of amphotericin B (0.75 mg/kg of body weight/day) or fluconazole (50 mg/kg/day). The number of Candida CFU in abscesses was significantly reduced (P<0.05) in mice receiving rmG-CSF prophylaxis (day -1 or day -1 through 2) compared with controls on day 8 of infection. Administration of rmG-CSF therapy alone (for 5 days starting on day 4 of infection) had no influence on the number of Candida CFU in abscesses. Amphotericin B treatment was significantly more effective than fluconazole treatment (3.41 log CFU/abscesses; 95% confidence interval [CI], 3.17 log CFU/abscesses; 3.65 versus 3.90 log CFU/abscesses; 95% CI, 3.66 log CFU/abscesses, 4.16 log CFU/abscesses; P<0.05). Therapeutic administration of rmG-CSF in conjunction with an antifungal agent showed a tendency towards a further reduction of Candida CFU in abscesses than antifungal treatment only. In conclusion, in this experimental model of intra-abdominal Candida abscesses, rmG-CSF administration did not have a detrimental influence on the course of infection. Amphotericin B treatment was most effective, and additional rmG-CSF therapy did not antagonize the effect of antifungal treatment. In contrast, addition of rmG-CSF therapy to antifungal treatment might further enhance the beneficial effect of the antifungal agent.
- Published
- 2003
- Full Text
- View/download PDF
34. Delayed clearance of intraabdominal abscesses caused by Candida albicans in tumor necrosis factor-alpha- and lymphotoxin-alpha-deficient mice.
- Author
-
Vonk AG, Netea MG, van Krieken JH, van der Meer JW, and Kullberg BJ
- Subjects
- Abdominal Abscess microbiology, Abdominal Abscess pathology, Animals, Candidiasis microbiology, Candidiasis pathology, Cells, Cultured, Colony Count, Microbial, Disease Models, Animal, Female, Granulocytes pathology, Interferon-gamma biosynthesis, Interleukin-10 biosynthesis, Lymphotoxin-alpha genetics, Macrophages pathology, Mice, Mice, Inbred C57BL, Mice, Knockout, Spleen immunology, Time Factors, Tumor Necrosis Factor-alpha genetics, Abdominal Abscess immunology, Candida albicans isolation & purification, Candidiasis immunology, Lymphotoxin-alpha deficiency, Tumor Necrosis Factor-alpha deficiency
- Abstract
The role of endogenous tumor necrosis factor-alpha (TNF) and lymphotoxin-alpha (LT) in a model of intraabdominal Candida sepsis and abscess formation was investigated. Significantly more abscesses were observed in TNF/LT double knockout (TNF(-/-)LT(-/-)) mice, compared with that in wild-type (TNF(+/+)LT(+/+)) mice. Outgrowth of Candida in abscesses of TNF(-/-)LT(-/-) mice was 10-fold increased on day 14 and 60-fold increased on day 21 of infection. The interleukin-10rcolon;interferon-gamma ratio, measured in supernatants of stimulated splenocytes, shifted from 131 for TNF(-/-)LT(-/-) mice and 13.9 for TNF(+/+)LT(+/+) mice on day 8 to 0.11 for TNF(-/-)LT(-/-) mice and 11.66 for TNF(+/+)LT(+/+) mice on day 14 of infection. The diminished host resistance is explained by an impaired extracellular killing capacity of granulocytes and a delayed development of a T helper 1 response in TNF(-/-)LT(-/-) mice. In conclusion, TNF and LT are critical to the stimulation of effector cells that leads to elimination of Candida from abscesses.
- Published
- 2002
- Full Text
- View/download PDF
35. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis.
- Author
-
Netea MG, Van Der Graaf CA, Vonk AG, Verschueren I, Van Der Meer JW, and Kullberg BJ
- Subjects
- Animals, Candidiasis immunology, Candidiasis microbiology, Cell Count, Chemokines biosynthesis, Chemokines, CXC biosynthesis, Interleukin-1 analysis, Kidney microbiology, Macrophages, Peritoneal immunology, Macrophages, Peritoneal physiology, Membrane Glycoproteins deficiency, Membrane Glycoproteins genetics, Mice, Mice, Inbred C3H, Mice, Knockout, Neutrophils immunology, Phagocytosis, Point Mutation, Receptors, Cell Surface deficiency, Receptors, Cell Surface genetics, Toll-Like Receptor 2, Toll-Like Receptor 4, Toll-Like Receptors, Tumor Necrosis Factor-alpha analysis, Candida albicans isolation & purification, Candidiasis metabolism, Drosophila Proteins, Membrane Glycoproteins physiology, Receptors, Cell Surface physiology
- Abstract
Toll-like receptors (TLRs) represent the main class of pattern-recognition receptors involved in sensing pathogenic microorganisms. The aim of the present study was to assess the role of TLR4 in the defense against Candida albicans infection. The outgrowth of C. albicans was 10-fold higher in TLR4-defective C3H/HeJ mice, compared with that in control C3H/HeN mice (P<.05). Production of tumor necrosis factor (TNF) and interleukin (IL)-1alpha and IL-1beta by mouse macrophages in response to C. albicans stimulation was not affected by TLR4, and the candidacidal capacities of the neutrophils and macrophages of C3H/HeJ mice were normal. In contrast, production of the CXC chemokines KC and macrophage inhibitory protein-2 was 40%-60% lower by the macrophages of C3H/HeJ mice (P<.05), which resulted in a 40% decrease in neutrophil recruitment to the site of infection. Candida-induced TNF and IL-1beta production by human peripheral blood mononuclear cells was significantly inhibited by blocking anti-TLR2 antibodies in vitro. In conclusion, TLR4-defective C3H/HeJ mice are more susceptible to C. albicans infection, and this is associated with impaired chemokine expression and neutrophil recruitment.
- Published
- 2002
- Full Text
- View/download PDF
36. Phagocytosis and intracellular killing of Candida albicans blastoconidia by neutrophils and macrophages: a comparison of different microbiological test systems.
- Author
-
Vonk AG, Wieland CW, Netea MG, and Kullberg BJ
- Subjects
- Animals, Female, Humans, Macrophages, Peritoneal immunology, Mice, Mice, Inbred C57BL, Mice, Inbred CBA, Mycology methods, Neutrophils immunology, Candida albicans physiology, Macrophages, Peritoneal microbiology, Neutrophils microbiology, Phagocytosis immunology
- Abstract
Polymorphonuclear neutrophils (PMN) and mononuclear phagocytes represent an important first line and effector function in the control of Candida infections. Their relative contribution to host defence is frequently assessed by means of microbiological assays. However, reported results are divergent and might well be associated with study design-related issues. In the present study, we compared frequently used microbiological candidacidal assays, with the purpose of determining the most adequate method for assessment of phagocytosis and intracellular killing. We concluded that microbiological assays using yeast-phagocyte suspensions are inappropriate for the assessment of intracellular killing of Candida blastoconidia by murine macrophages, due to adherence or clumping of cells. In contrast, an adherent monolayer of phagocytes can be applied as a single microbiological assay to independently study the process of phagocytosis and intracellular killing, by exudate peritoneal macrophages as well as exudate peritoneal PMN.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.